These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18209098)

  • 1. Tumor immunotherapy by epicutaneous immunization requires langerhans cells.
    Stoitzner P; Green LK; Jung JY; Price KM; Tripp CH; Malissen B; Kissenpfennig A; Hermans IF; Ronchese F
    J Immunol; 2008 Feb; 180(3):1991-8. PubMed ID: 18209098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy.
    Flacher V; Sparber F; Tripp CH; Romani N; Stoitzner P
    Cancer Immunol Immunother; 2009 Jul; 58(7):1137-47. PubMed ID: 18677477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen Uptake by Langerhans Cells Is Required for the Induction of Regulatory T Cells and the Acquisition of Tolerance During Epicutaneous Immunotherapy in OVA-Sensitized Mice.
    Dioszeghy V; Mondoulet L; Laoubi L; Dhelft V; Plaquet C; Bouzereau A; Dupont C; Sampson H
    Front Immunol; 2018; 9():1951. PubMed ID: 30233572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycolipids injected into the skin are presented to NKT cells in the draining lymph node independently of migratory skin dendritic cells.
    Tripp CH; Sparber F; Hermans IF; Romani N; Stoitzner P
    J Immunol; 2009 Jun; 182(12):7644-54. PubMed ID: 19494288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.
    Mitsui H; Okamoto T; Kanzaki M; Inozume T; Shibagaki N; Shimada S
    Br J Dermatol; 2010 Jan; 162(1):29-41. PubMed ID: 19863514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of skin-derived dendritic cells in CD8+ T cell priming following immunization with lentivectors.
    Furmanov K; Elnekave M; Lehmann D; Clausen BE; Kotton DN; Hovav AH
    J Immunol; 2010 May; 184(9):4889-97. PubMed ID: 20357252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented induction of CD8+ cytotoxic T-cell response and antitumour resistance by T helper type 1-inducing peptide.
    Kikuchi T; Uehara S; Ariga H; Tokunaga T; Kariyone A; Tamura T; Takatsu K
    Immunology; 2006 Jan; 117(1):47-58. PubMed ID: 16423040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Langerhans cells as targets for immunotherapy against skin cancer.
    Stoitzner P; Sparber F; Tripp CH
    Immunol Cell Biol; 2010; 88(4):431-7. PubMed ID: 20351746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control.
    Vianello F; Papeta N; Chen T; Kraft P; White N; Hart WK; Kircher MF; Swart E; Rhee S; Palù G; Irimia D; Toner M; Weissleder R; Poznansky MC
    J Immunol; 2006 Mar; 176(5):2902-14. PubMed ID: 16493048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Langerhans cells mediate the skin-induced tolerance to ovalbumin via Langerin in a murine model.
    Luo Y; Wang S; Liu X; Wen H; Li W; Yao X
    Allergy; 2019 Sep; 74(9):1738-1747. PubMed ID: 30964950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock protein-antigen fusions lose their enhanced immunostimulatory capacity after endotoxin depletion.
    Marincek BC; Kühnle MC; Srokowski C; Schild H; Hämmerling G; Momburg F
    Mol Immunol; 2008 Nov; 46(1):181-91. PubMed ID: 18804283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Langerhans cells cross-present antigen derived from skin.
    Stoitzner P; Tripp CH; Eberhart A; Price KM; Jung JY; Bursch L; Ronchese F; Romani N
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7783-8. PubMed ID: 16672373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways.
    Pouniotis DS; Esparon S; Apostolopoulos V; Pietersz GA
    Immunol Cell Biol; 2011 Nov; 89(8):904-13. PubMed ID: 21383765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Langerhans cells prime IL-17-producing T cells and dampen genital cytotoxic responses following mucosal immunization.
    Hervouet C; Luci C; Rol N; Rousseau D; Kissenpfennig A; Malissen B; Czerkinsky C; Anjuère F
    J Immunol; 2010 May; 184(9):4842-51. PubMed ID: 20351191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor.
    Lugade AA; Moran JP; Gerber SA; Rose RC; Frelinger JG; Lord EM
    J Immunol; 2005 Jun; 174(12):7516-23. PubMed ID: 15944250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
    Hao S; Yuan J; Xiang J
    J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin inflammation is not sufficient to break tolerance induced against a novel antigen.
    Holcmann M; Stoitzner P; Drobits B; Luehrs P; Stingl G; Romani N; Maurer D; Sibilia M
    J Immunol; 2009 Jul; 183(2):1133-43. PubMed ID: 19570825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin.
    Luci C; Hervouet C; Rousseau D; Holmgren J; Czerkinsky C; Anjuère F
    J Immunol; 2006 Mar; 176(5):2749-57. PubMed ID: 16493030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injection of soluble antigen into the anterior chamber of the eye induces expansion and functional unresponsiveness of antigen-specific CD8+ T cells.
    McKenna KC; Xu Y; Kapp JA
    J Immunol; 2002 Nov; 169(10):5630-7. PubMed ID: 12421942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo augmentation of tumor-specific CTL responses by class I/peptide antigen complexes on microspheres (large multivalent immunogen).
    Goldberg J; Shrikant P; Mescher MF
    J Immunol; 2003 Jan; 170(1):228-35. PubMed ID: 12496404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.